280 likes | 442 Views
Archived File. The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated. See the OER Public Archive Home Page for more details about archived files. Andrea Kopstein, PhD.
E N D
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated. See the OER Public Archive Home Page for more details about archived files.
Andrea Kopstein, PhD Evaluation of CSR Peer Review Pilots PRAC - February 1, 2010 National Institutes of HealthU.S. Department of Health and HumanServices
ARRA INITIATIVES • Challenge Grants (RC1) • Competitive Revisions • Grand Opportunities (“GO” Grants) • High End Instrumentation • Small Business • Academic Research EnhancementAward (AREA) • Community Infrastructure
Applications Reviewed and Reviewers Used by CSR in June 2008 and 2009
The ARRA Reviewers • Challenge review used “editorial board” format – two stages • Survey - 14,683 ARRA reviewers invited to participate • 7,653 individuals completed on-line survey (response rate of 52%) • 6,548 mail reviewers (Stage 1) • 1,105 in-person reviewers (Stage 2)
Order of Review/Clustering Pilot • February-March 2009 • Evaluation invited 663 reviewers and 29 SROs • Pilot included review of 1,628 applications • 415 reviewers and 25 SROs responded • Response rate: 63% percent of reviewers, and 86% of the SROs
Preliminary rank order of review Discussion of applications in order (“best to worst”) of average preliminary impact score from assigned reviewers: Requirement: • Reviewers participate in entire meeting. • Discourages telephone reviewers for 1 or 2 applications
Clustering Pilot • Clustering: “like” applications grouped together for peer review (such as clinical applications, by grant activity (e.g. R01, R21 etc.) • “new investigator/early stage investigator” (NI/ESI) – only for R01s
Transformative Research Projects Program - T-R01s • “support exceptionally innovative, high risk, original, and/or unconventional research with the potential to create new or challenge existing scientific paradigms.” • “Editorial board” format – three stages • Evaluation - stage 1/3 reviewers and applicants (prior to review) • 431/700 applicants and 7/11 reviewers responded, 62% for applicants & 63% for reviewers.
T-R01 • 740 applications received • 720 reviewed (3 stage) • 42 funded ($32 million) • 431 applicants and 7 reviewers responded, response rates of 62% for applicants and 63% for reviewers.
T-R01 Applicants • Majority Caucasian and non-Hispanic: • Caucasian: 71%; non-Hispanic/Latino: 86%; Asian: 21%; African Americans: 2%; American Indians: <1% • Majority male (79% men, 21% women)
Applicant Findings • Two commonly occurring research areas: molecular/cellular/chemical biologists and clinical/translational research • 80% of applicants claimed proposed concept was a significant departure from usual research
Applicants – Possibility of Receiving Funding From other Sources
Reviewer opinions of mail reviewers having appropriate expertise …….
T-R01 Reviewers • 50% of applicants understood project goals • 25% of applicants capable of conducting transformative research